Sude Eris

4PUBLICATIONS
12CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 24, 2026
Correction: Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer.

|May 25, 2025
Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer.

|Apr 03, 2025
Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.

Ece Cakiroglu, Sude Eris, Ozden Oz

|Mar 14, 2025
Escape from TGF-β-induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells.

Minenur Kalyoncu, Dilara Demirci, Sude Eris

Pageof 1

Frequent Collaborators

4 joint publications

Gökhan Karakülah

4 joint publications

Serif Senturk

2 joint publications

Ece Cakiroglu

2 joint publications

Nazife Ege Gulfirat